Nagaileben Co Ltd

Nagaileben maintains a strong liquidity position, with cash and equivalents amounting to ¥24.25 billion, representing 54.2% of total assets. The company's liquidity FPT (free cash flow to total liabilities) is robust, and its current ratio of 14.44 indicates a high ability to meet short-term obligations. The absence of long-term debt and a debt-to-equity ratio of 0.0 further reinforce its conservative capital structure. Profitability metrics show that Nagaileben's return on equity (ROE) of 6.23% and return on assets (ROA) of 5.76% are in line with industry norms. The company's gross margin of 39.5% and operating margin of 21.1% are consistent with the industry's preferred metrics, indicating efficient cost management and pricing power. The company's revenue is primarily concentrated in Japan, with disclosed segments including medical wear and shoes. While the input data does not specify geographic breakdowns, the company's operations are largely domestic, and its supply chain is partially reliant on its manufacturing subsidiary for medical wear. Looking ahead, Nagaileben is projected to grow revenue by 4.2% in the current fiscal year and 3.8% in the next, based on analyst estimates. The company's free cash flow of ¥575 million and operating cash flow of ¥2.18 billion support its ability to fund operations and potentially invest in growth opportunities. Risk factors for Nagaileben are minimal, with low liquidity and dilution risk scores. The company has no immediate filing-based liquidity or dilution flags, and its capital structure is free of long-term debt. The absence of dilution potential and the low probability of near-term equity issuance suggest a stable ownership structure. Recent events include the publication of the latest financial results and analyst estimates. The company's last actual EPS of ¥83.24 was slightly below the mean estimate of ¥91.80, and its revenue of ¥16.98 billion was below the mean estimate of ¥17.7 billion. These discrepancies may indicate potential challenges in meeting growth expectations.